XENOPHA Trademark

Trademark Overview


On Monday, August 31, 2020, a trademark application was filed for XENOPHA with the United States Patent and Trademark Office. The USPTO has given the XENOPHA trademark a serial number of 79298960. The federal status of this trademark filing is REGISTERED as of Tuesday, September 28, 2021. This trademark is owned by MECCELLIS BIOTECH. The XENOPHA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for breast, thoracic, digestive, pelvic, plastic surgery and for human tissue repair, regeneration or strengthening; biological and surgical implants, namely, skin tissue, acellular dermal matrix and resorbing biopolymer intended for subsequent implantation; biological skin tissue implants intended for breast, thoracic, digestive, pelvic and plastic surgery; biological skin tissue implants intended for human tissue repair, regeneration or strengthening; acellular matrices in the nature of biological skin tissue used as implants intended for surgery biological skin tissue matrices for human tissue repair, regeneration or strengthening
xenopha

General Information


Serial Number79298960
Word MarkXENOPHA
Filing DateMonday, August 31, 2020
Status700 - REGISTERED
Status DateTuesday, September 28, 2021
Registration Number6495692
Registration DateTuesday, September 28, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 13, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for breast, thoracic, digestive, pelvic, plastic surgery and for human tissue repair, regeneration or strengthening; biological and surgical implants, namely, skin tissue, acellular dermal matrix and resorbing biopolymer intended for subsequent implantation; biological skin tissue implants intended for breast, thoracic, digestive, pelvic and plastic surgery; biological skin tissue implants intended for human tissue repair, regeneration or strengthening; acellular matrices in the nature of biological skin tissue used as implants intended for surgery biological skin tissue matrices for human tissue repair, regeneration or strengthening

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 4, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMECCELLIS BIOTECH
Party Type30 - Original Registrant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Party NameMECCELLIS BIOTECH
Party Type20 - Owner at Publication
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Party NameMECCELLIS BIOTECH
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Trademark Events


Event DateEvent Description
Monday, April 4, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, March 16, 2022FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, March 16, 2022FINAL DISPOSITION PROCESSED
Tuesday, December 28, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 28, 2021REGISTERED-PRINCIPAL REGISTER
Monday, July 19, 2021NOTIFICATION PROCESSED BY IB
Tuesday, July 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 13, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 30, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 30, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 23, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 4, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 3, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 3, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, February 14, 2021REFUSAL PROCESSED BY IB
Thursday, January 28, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, January 28, 2021REFUSAL PROCESSED BY MPU
Tuesday, January 12, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, January 11, 2021NON-FINAL ACTION WRITTEN
Tuesday, January 5, 2021ASSIGNED TO EXAMINER
Tuesday, December 8, 2020APPLICATION FILING RECEIPT MAILED
Friday, December 4, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 3, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB